Sophia Zackrisson
Research group manager, Principal investigator, Professor, MD, PhD
Neoadjuvant breast cancer treatment response; tumor size evaluation through different conventional imaging modalities in the NeoDense study
Author
Summary, in English
Neoadjuvant chemotherapy (NACT) is offered to an increasing number of breast cancer (BC) patients, and comprehensive monitoring of treatment response is of utmost importance. Several imaging modalities are available to follow tumor response, although likely to provide different clinical information. We aimed to examine the association between early radiological response by three conventional imaging modalities and pathological complete response (pCR). Further, we investigated the agreement between these modalities pre-, during, and post-NACT, and the accuracy of predicting pathological residual tumor burden by these imaging modalities post-NACT.
Department/s
- Breastcancer
- LUCC: Lund University Cancer Centre
- Breast cancer prevention & intervention
- Medical Radiation Physics, Malmö
- Breast cancer treatment
- The Liquid Biopsy and Tumor Progression in Breast Cancer
- Breast Cancer Surgery
- Surgery (Lund)
- EpiHealth: Epidemiology for Health
- Radiology Diagnostics, Malmö
Publishing year
2020
Language
English
Pages
1528-1537
Publication/Series
Acta Oncologica
Volume
59
Issue
12
Document type
Article
Publisher
Taylor & Francis
Topic
- Cancer and Oncology
Keywords
- SDG 3 - Good Health and Well-being
Status
Published
Research group
- Breast cancer prevention & intervention
- Medical Radiation Physics, Malmö
- The Liquid Biopsy and Tumor Progression in Breast Cancer
- Breast Cancer Surgery
- Radiology Diagnostics, Malmö
ISBN/ISSN/Other
- ISSN: 1651-226X